SPI
16 709,95
|
-47,10
|
-0,28%
|
Analysen zu SPI-Werten
17:02 | UBS Halten | DZ BANK | |
16:56 | ABB Kaufen | DZ BANK | |
09:07 | UBS Overweight | JP Morgan Chase & Co. | |
07:01 | DocMorris Sell | UBS AG | |
06.02.25 | Nestlé Neutral | UBS AG | |
06.02.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
06.02.25 | Roche Sell | Goldman Sachs Group Inc. | |
06.02.25 | UBS Buy | Goldman Sachs Group Inc. | |
05.02.25 | Zurich Insurance Hold | Deutsche Bank AG | |
05.02.25 | Nestlé Market-Perform | Bernstein Research | |
04.02.25 | Roche Sell | Deutsche Bank AG | |
04.02.25 | UBS Buy | Goldman Sachs Group Inc. | |
04.02.25 | UBS Hold | Deutsche Bank AG | |
04.02.25 | UBS Overweight | JP Morgan Chase & Co. | |
04.02.25 | Novartis Buy | Deutsche Bank AG | |
04.02.25 | UBS Outperform | RBC Capital Markets | |
04.02.25 | UBS Buy | Goldman Sachs Group Inc. | |
04.02.25 | DocMorris Buy | Jefferies & Company Inc. | |
03.02.25 | Roche Underweight | JP Morgan Chase & Co. | |
03.02.25 | Novartis Hold | Deutsche Bank AG | |
03.02.25 | Novartis Kaufen | DZ BANK | |
03.02.25 | Nestlé Neutral | UBS AG | |
03.02.25 | Novartis Buy | UBS AG | |
31.01.25 | Roche Sell | Deutsche Bank AG | |
31.01.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
31.01.25 | Novartis Buy | UBS AG | |
31.01.25 | ABB Sell | Deutsche Bank AG | |
31.01.25 | Roche Neutral | UBS AG | |
31.01.25 | UBS Overweight | JP Morgan Chase & Co. | |
31.01.25 | Novartis Outperform | Bernstein Research | |
31.01.25 | Novartis Hold | Jefferies & Company Inc. | |
31.01.25 | ABB Neutral | UBS AG | |
30.01.25 | Roche Outperform | Bernstein Research | |
30.01.25 | ABB Underperform | Bernstein Research | |
30.01.25 | Roche Underweight | JP Morgan Chase & Co. | |
30.01.25 | ABB Neutral | UBS AG | |
30.01.25 | Roche Neutral | UBS AG | |
30.01.25 | Roche Sell | Goldman Sachs Group Inc. | |
30.01.25 | ABB Neutral | Goldman Sachs Group Inc. | |
30.01.25 | ABB Sector Perform | RBC Capital Markets |